who should not use glp 1 Long-term Success of GLP-1s Hinges on More Than Just a Prescription GLP-1s Don't Work for Everyone:

This is not because the medications are "worse" for you

Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-analysis of economic evaluation studies

Brello appears to have moved between compounding pharmacies at some point, and this transition created supply chain disruptions that affected a significant number of users

Curr Opin Gastroen

They ate skin-on chicken, simmered soup bones for hours, and made use of every part of the animal

The main risk associated with GHK-Cu in clinical practice is sourcing quality, unregulated compounding pharmacies or unverified online vendors may produce peptide preparations with impurities that cause reactions incorrectly attributed to the peptide itself